ANTIVIRAL THERAPY IN PANDEMIC INFLUENZA

Abstract

Pandemic influenza (PI) might be seen in the people who has no immunity against the new influenza virus (H1N1) previously. In the past, PI has caused many mortality and morbidity. Although antiviral therapy is not recommended for most of the patients with mild illness, it is strongly recommended for some group of the patients who are under 2 year-old, >65 year-old, pregnant and younger than 19 and also being taken aspirin for a long time. Neuraminidase inhibitors (NI) (oseltamivir, zanamivir) are preferred for the antiviral therapy. New drugs are expected to be turned out in this area.